Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 5 studies | 26% ± 9% |
Insufficient scRNA-seq data for expression of S1PR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1120.87 | 1806 / 1809 | 100% | 37.48 | 472 / 472 |
breast | 100% | 1019.85 | 458 / 459 | 100% | 14.82 | 1115 / 1118 |
lung | 100% | 2469.01 | 578 / 578 | 99% | 14.63 | 1139 / 1155 |
ovary | 99% | 953.36 | 178 / 180 | 98% | 13.23 | 420 / 430 |
uterus | 99% | 1476.32 | 169 / 170 | 97% | 15.49 | 445 / 459 |
prostate | 100% | 1279.87 | 245 / 245 | 95% | 7.29 | 479 / 502 |
bladder | 100% | 1454.33 | 21 / 21 | 95% | 11.02 | 480 / 504 |
thymus | 98% | 650.64 | 643 / 653 | 94% | 13.03 | 569 / 605 |
esophagus | 98% | 888.63 | 1419 / 1445 | 89% | 6.86 | 162 / 183 |
intestine | 99% | 792.40 | 956 / 966 | 88% | 7.09 | 462 / 527 |
stomach | 95% | 629.90 | 340 / 359 | 88% | 9.01 | 253 / 286 |
adrenal gland | 95% | 415.26 | 246 / 258 | 80% | 6.96 | 185 / 230 |
pancreas | 77% | 258.81 | 251 / 328 | 99% | 13.37 | 176 / 178 |
liver | 84% | 496.46 | 190 / 226 | 84% | 11.46 | 343 / 406 |
kidney | 73% | 312.07 | 65 / 89 | 70% | 4.76 | 633 / 901 |
brain | 21% | 52.76 | 568 / 2642 | 96% | 12.05 | 676 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 12.62 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 48.24 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.74 | 1 / 1 |
adipose | 100% | 1210.51 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 94% | 675.18 | 812 / 861 | 0% | 0 | 0 / 0 |
spleen | 92% | 320.06 | 222 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 83% | 405.13 | 1108 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 35% | 551.17 | 326 / 929 | 0% | 0 | 0 / 0 |
muscle | 8% | 22.55 | 61 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903142 | Biological process | positive regulation of establishment of endothelial barrier |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0003376 | Biological process | sphingosine-1-phosphate receptor signaling pathway |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0090394 | Biological process | negative regulation of excitatory postsynaptic potential |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0046847 | Biological process | filopodium assembly |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0019222 | Biological process | regulation of metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0008289 | Molecular function | lipid binding |
GO_0005178 | Molecular function | integrin binding |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
GO_0038036 | Molecular function | sphingosine-1-phosphate receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | S1PR2 |
Protein name | Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5) |
Synonyms | EDG5 |
Description | FUNCTION: Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P) . S1P is a bioactive lysophospholipid that elicits diverse physiological effects on most types of cells and tissues . When expressed in rat HTC4 hepatoma cells, is capable of mediating S1P-induced cell proliferation and suppression of apoptosis . Receptor for the chemokine-like protein FAM19A5 . Mediates the inhibitory effect of FAM19A5 on vascular smooth muscle cell proliferation and migration (By similarity). . |
Accessions | O95136 ENST00000646641.1 |